サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1487502

軟骨変性市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

Cartilage Degeneration Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 196 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
軟骨変性市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測
出版日: 2024年04月19日
発行: Transparency Market Research
ページ情報: 英文 196 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

軟骨変性市場- 調査範囲

TMRの軟骨変性症の世界市場に関する調査レポートは、2024年から2034年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の軟骨変性症市場の収益と予測を提供します。また、2024年から2034年までの世界の軟骨変性市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、軟骨変性症市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照しました。

市場スナップショット
2023年の市場規模 116億米ドル
2034年の市場価値 249億米ドル
CAGR 7.1%

本レポートでは、世界の軟骨変性市場の競合情勢について掘り下げています。世界の軟骨変性症市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートでプロファイリングされた世界の軟骨変性市場のプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 市場分析と予測、2020-2034年

第5章 主要洞察

  • パイプライン分析
  • 主要手技タイプ/ブランド分析
  • 主要M&A
  • COVID-19パンデミックの業界への影響

第6章 世界市場分析と予測：施術タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：施術タイプ別、2020年～2034年
    • 関節置換術
    • 軟骨形成術
    • 骨軟骨移植術
    • マイクロフラクチャー
    • 半月板移植
    • 細胞ベースの軟骨表面置換術
    • 自家軟骨細胞移植術
    • その他
  • 市場魅力度分析：施術タイプ別

第7章 世界市場分析・予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：用途別、2020年～2034年
    • 膝関節
    • 股関節
    • その他
  • 市場魅力度分析：用途別

第8章 世界市場分析・予測：治療提供チャネル別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：治療提供チャネル別、2020年～2034年
    • 病院
    • 学術・研究機関
    • 専門クリニック
    • 外来手術センター
    • その他
  • 市場魅力度分析：治療提供チャネル別

第9章 世界市場分析・予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020年～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と展望

第14章 中東・アフリカ市場の分析と展望

第15章 競合情勢

  • 市場競合マトリックス（企業階層別・企業規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • Smith & Nephew plc
    • B. Braun
    • Medtronic plc
    • Johnson & Johnson（DePuy Synthes）
    • Osiris Therapeutics, Inc.
    • Vericel Corporation
    • Anika Therapeutics Inc.
    • MEDIPOST Co., Ltd.
    • CONMED Corporation
    • Arthrex, Inc.
図表

List of Tables

  • Table 01: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
  • Table 02: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 03: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2020-2034
  • Table 04: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
  • Table 07: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 08: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2020-2034
  • Table 09: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
  • Table 11: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 12: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2020-2034
  • Table 13: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
  • Table 15: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 16: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2020-2034
  • Table 17: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
  • Table 19: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 20: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2020-2034
  • Table 21: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
  • Table 23: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 24: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2020-2034

List of Figures

  • Figure 01: Global Cartilage Degeneration Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Cartilage Degeneration Market Revenue (US$ Mn), by Procedure Type, 2023
  • Figure 03: Global Cartilage Degeneration Market Value Share, by Procedure Type, 2023
  • Figure 04: Global Cartilage Degeneration Market Revenue (US$ Mn), by Application, 2023
  • Figure 05: Global Cartilage Degeneration Market Value Share, by Application, 2023
  • Figure 06: Global Cartilage Degeneration Market Revenue (US$ Mn), by Treatment Delivery Channel, 2023
  • Figure 07: Global Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2023
  • Figure 08: Global Cartilage Degeneration Market Value Share, by Region, 2023
  • Figure 09: Global Cartilage Degeneration Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 10: Global Cartilage Degeneration Market Value Share Analysis, by Procedure Type, 2023 and 2034
  • Figure 11: Global Cartilage Degeneration Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Cartilage Degeneration Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 13: Global Cartilage Degeneration Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 14: Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel, 2023 and 2034
  • Figure 15: Global Cartilage Degeneration Market Attractiveness Analysis, by Treatment Delivery Channel, 2024-2034
  • Figure 16: Global Cartilage Degeneration Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Cartilage Degeneration Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Cartilage Degeneration Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Cartilage Degeneration Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Cartilage Degeneration Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Cartilage Degeneration Market Value Share Analysis, by Procedure Type, 2023 and 2034
  • Figure 22: North America Cartilage Degeneration Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 23: North America Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel, 2023 and 2034
  • Figure 24: North America Cartilage Degeneration Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Cartilage Degeneration Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 26: North America Cartilage Degeneration Market Attractiveness Analysis, by Treatment Delivery Channel, 2024-2034
  • Figure 27: Europe Cartilage Degeneration Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Cartilage Degeneration Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Cartilage Degeneration Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Cartilage Degeneration Market Value Share Analysis, by Procedure Type, 2023 and 2034
  • Figure 31: Europe Cartilage Degeneration Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 32: Europe Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel, 2023 and 2034
  • Figure 33: Europe Cartilage Degeneration Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Cartilage Degeneration Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 35: Europe Cartilage Degeneration Market Attractiveness Analysis, by Treatment Delivery Channel, 2024-2034
  • Figure 36: Asia Pacific Cartilage Degeneration Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Cartilage Degeneration Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Cartilage Degeneration Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Cartilage Degeneration Market Value Share Analysis, by Procedure Type, 2023 and 2034
  • Figure 40: Asia Pacific Cartilage Degeneration Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 41: Asia Pacific Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel, 2023 and 2034
  • Figure 42: Asia Pacific Cartilage Degeneration Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Cartilage Degeneration Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 44: Asia Pacific Cartilage Degeneration Market Attractiveness Analysis, by Treatment Delivery Channel, 2024-2034
  • Figure 45: Latin America Cartilage Degeneration Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Cartilage Degeneration Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Cartilage Degeneration Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Cartilage Degeneration Market Value Share Analysis, by Procedure Type, 2023 and 2034
  • Figure 49: Latin America Cartilage Degeneration Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 50: Latin America Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel, 2023 and 2034
  • Figure 51: Latin America Cartilage Degeneration Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Cartilage Degeneration Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 53: Latin America Cartilage Degeneration Market Attractiveness Analysis, by Treatment Delivery Channel, 2024-2034
  • Figure 54: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Cartilage Degeneration Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Cartilage Degeneration Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Cartilage Degeneration Market Value Share Analysis, by Procedure Type, 2023 and 2034
  • Figure 58: Middle East & Africa Cartilage Degeneration Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 59: Middle East & Africa Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel, 2023 and 2034
  • Figure 60: Middle East & Africa Cartilage Degeneration Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Cartilage Degeneration Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 62: Middle East & Africa Cartilage Degeneration Market Attractiveness Analysis, by Treatment Delivery Channel, 2024-2034
目次
Product Code: TMRGL13229

Cartilage Degeneration Market - Scope of Report

TMR's report on the global cartilage degeneration market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global cartilage degeneration market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cartilage degeneration market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cartilage degeneration market.

Market Snapshot
Market Value in 2023US$ 11.6 Bn
Market Value in 2034US$ 24.9 Bn
CAGR7.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cartilage degeneration market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cartilage degeneration market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cartilage degeneration market.

The report delves into the competitive landscape of the global cartilage degeneration market. Key players operating in the global cartilage degeneration market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cartilage degeneration market profiled in this report.

Key Questions Answered in Global cartilage degeneration Market Report:

  • What is the sales/revenue generated by cartilage degeneration across all regions during the forecast period?
  • What are the opportunities in the global cartilage degeneration market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cartilage Degeneration Market - Research Objectives and Research Approach

The comprehensive report on the global cartilage degeneration market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cartilage degeneration market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cartilage degeneration market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Cartilage Degeneration Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Procedure Type Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Cartilage Degeneration Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Procedure Type /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Cartilage Degeneration Market Analysis and Forecast, by Procedure Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Procedure Type, 2020-2034
    • 6.3.1. Joint Replacements
    • 6.3.2. Chondroplasty
    • 6.3.3. Osteochondral Transplants
    • 6.3.4. Microfracture
    • 6.3.5. Meniscus Transplants
    • 6.3.6. Cell-based Cartilage Resurfacing
    • 6.3.7. Autologous Chondrocyte Implantation
    • 6.3.8. Others
  • 6.4. Market Attractiveness Analysis, by Procedure Type

7. Global Cartilage Degeneration Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020-2034
    • 7.3.1. Knee
    • 7.3.2. Hip
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Cartilage Degeneration Market Analysis and Forecast, by Treatment Delivery Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Treatment Delivery Channel, 2020-2034
    • 8.3.1. Hospitals
    • 8.3.2. Academic & Research Institutes
    • 8.3.3. Specialty Clinics
    • 8.3.4. Ambulatory Surgical Centers
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by Treatment Delivery Channel

9. Global Cartilage Degeneration Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Cartilage Degeneration Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Procedure Type, 2020-2034
    • 10.3.1. Joint Replacements
    • 10.3.2. Chondroplasty
    • 10.3.3. Osteochondral Transplants
    • 10.3.4. Microfracture
    • 10.3.5. Meniscus Transplants
    • 10.3.6. Cell-based Cartilage Resurfacing
    • 10.3.7. Autologous Chondrocyte Implantation
    • 10.3.8. Others
  • 10.4. Market Value Forecast, by Application, 2020-2034
    • 10.4.1. Knee
    • 10.4.2. Hip
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Treatment Delivery Channel, 2020-2034
    • 10.5.1. Hospitals
    • 10.5.2. Academic & Research Institutes
    • 10.5.3. Specialty Clinics
    • 10.5.4. Ambulatory Surgical Centers
    • 10.5.5. Others
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Procedure Type
    • 10.7.2. By Application
    • 10.7.3. By Treatment Delivery Channel
    • 10.7.4. By Country

11. Europe Cartilage Degeneration Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Procedure Type, 2020-2034
    • 11.3.1. Joint Replacements
    • 11.3.2. Chondroplasty
    • 11.3.3. Osteochondral Transplants
    • 11.3.4. Microfracture
    • 11.3.5. Meniscus Transplants
    • 11.3.6. Cell-based Cartilage Resurfacing
    • 11.3.7. Autologous Chondrocyte Implantation
    • 11.3.8. Others
  • 11.4. Market Value Forecast, by Application, 2020-2034
    • 11.4.1. Knee
    • 11.4.2. Hip
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Treatment Delivery Channel, 2020-2034
    • 11.5.1. Hospitals
    • 11.5.2. Academic & Research Institutes
    • 11.5.3. Specialty Clinics
    • 11.5.4. Ambulatory Surgical Centers
    • 11.5.5. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Procedure Type
    • 11.7.2. By Application
    • 11.7.3. By Treatment Delivery Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Cartilage Degeneration Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Procedure Type, 2020-2034
    • 12.3.1. Joint Replacements
    • 12.3.2. Chondroplasty
    • 12.3.3. Osteochondral Transplants
    • 12.3.4. Microfracture
    • 12.3.5. Meniscus Transplants
    • 12.3.6. Cell-based Cartilage Resurfacing
    • 12.3.7. Autologous Chondrocyte Implantation
    • 12.3.8. Others
  • 12.4. Market Value Forecast, by Application, 2020-2034
    • 12.4.1. Knee
    • 12.4.2. Hip
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Treatment Delivery Channel, 2020-2034
    • 12.5.1. Hospitals
    • 12.5.2. Academic & Research Institutes
    • 12.5.3. Specialty Clinics
    • 12.5.4. Ambulatory Surgical Centers
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Procedure Type
    • 12.7.2. By Application
    • 12.7.3. By Treatment Delivery Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Cartilage Degeneration Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Procedure Type, 2020-2034
    • 13.3.1. Joint Replacements
    • 13.3.2. Chondroplasty
    • 13.3.3. Osteochondral Transplants
    • 13.3.4. Microfracture
    • 13.3.5. Meniscus Transplants
    • 13.3.6. Cell-based Cartilage Resurfacing
    • 13.3.7. Autologous Chondrocyte Implantation
    • 13.3.8. Others
  • 13.4. Market Value Forecast, by Application, 2020-2034
    • 13.4.1. Knee
    • 13.4.2. Hip
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Treatment Delivery Channel, 2020-2034
    • 13.5.1. Hospitals
    • 13.5.2. Academic & Research Institutes
    • 13.5.3. Specialty Clinics
    • 13.5.4. Ambulatory Surgical Centers
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Procedure Type
    • 13.7.2. By Application
    • 13.7.3. By Treatment Delivery Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Cartilage Degeneration Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Procedure Type, 2020-2034
    • 14.3.1. Joint Replacements
    • 14.3.2. Chondroplasty
    • 14.3.3. Osteochondral Transplants
    • 14.3.4. Microfracture
    • 14.3.5. Meniscus Transplants
    • 14.3.6. Cell-based Cartilage Resurfacing
    • 14.3.7. Autologous Chondrocyte Implantation
    • 14.3.8. Others
  • 14.4. Market Value Forecast, by Application, 2020-2034
    • 14.4.1. Knee
    • 14.4.2. Hip
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Treatment Delivery Channel, 2020-2034
    • 14.5.1. Hospitals
    • 14.5.2. Academic & Research Institutes
    • 14.5.3. Specialty Clinics
    • 14.5.4. Ambulatory Surgical Centers
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Procedure Type
    • 14.7.2. By Application
    • 14.7.3. By Treatment Delivery Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Zimmer Biomet Holdings, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Procedure Type Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Stryker Corporation
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Procedure Type Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Smith & Nephew plc
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Procedure Type Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. B. Braun
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Procedure Type Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Medtronic plc
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Procedure Type Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Johnson & Johnson (DePuy Synthes)
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Procedure Type Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Osiris Therapeutics, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Procedure Type Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Vericel Corporation
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Procedure Type Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Anika Therapeutics Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Procedure Type Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. MEDIPOST Co., Ltd.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Procedure Type Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. CONMED Corporation
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Procedure Type Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Arthrex, Inc.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Procedure Type Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview